Growth Metrics

PAVmed (PAVM) Gross Profit (2021 - 2025)

PAVmed has reported Gross Profit over the past 5 years, most recently at -$703000.0 for Q4 2025.

  • For Q4 2025, Gross Profit fell 384.83% year-over-year to -$703000.0; the TTM value through Dec 2025 reached -$1.0 million, up 93.52%, while the annual FY2025 figure was -$817000.0, 90.54% up from the prior year.
  • Gross Profit for Q4 2025 was -$703000.0 at PAVmed, down from -$50000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $56000.0 in Q3 2021 and troughed at -$11.7 million in Q4 2023.
  • A 5-year average of -$2.1 million and a median of -$695000.0 in 2024 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: plummeted 8421.43% in 2022 and later soared 98.76% in 2024.
  • Year by year, Gross Profit stood at -$141000.0 in 2021, then tumbled by 3904.96% to -$5.6 million in 2022, then crashed by 107.63% to -$11.7 million in 2023, then soared by 98.76% to -$145000.0 in 2024, then crashed by 384.83% to -$703000.0 in 2025.
  • Business Quant data shows Gross Profit for PAVM at -$703000.0 in Q4 2025, -$50000.0 in Q3 2025, and -$35000.0 in Q2 2025.